Acceptability of three novel lipid-based nutrient supplements among Malawian XXXX and their caregivers.

@entity24901 @entity1 @entity2829
We tested the acceptability of three new lipid-based nutrient supplements (LNSs) in two independent phases among 18 8-12-month-old healthy rural Malawians and their caregivers. In phase 1, acceptability was assessed by offering three new LNSs in random order, and an @entity24901 already determined to be acceptable, Nutributter(  ), each added to 30 g of warm @entity2829 porridge over three consecutive days. In phase 2, @entity1 from each village were provided one of the new supplements for a 2-week home-use trial. Outcome measures included the amount consumed, time completion of the dose and the maternal rating of likeability on a 5-point scale. The supplements were rated acceptable if consumption was over 50% of the offered dose in phase 1. The mean (95% confidence interval) proportion of the @entity24901 test meals consumed under direct observation was 88% (82-94%) for @entity24901 -10gM, 90% (84-95%) for @entity24901 -20gM, 87% (79-95%) for @entity24901 -20gNoM, and 86% (83-90%) for Nutributter. The median (25th and 75th centile) time (minutes) for completing the offered test meal was 4 (2, 7) for @entity24901 -10gM, 5 (3, 6) for @entity24901 -20gM, 4 (3, 8) for @entity24901 -20gNoM and 4 (2, 6) for Nutributter. During both phases, almost all caregivers rated all study foods very likeable for themselves and their @entity1 , with mean scores slightly lower among the caregivers than among the @entity1 . In the home-use phase, the test foods were almost exclusively used by the study @entity1 with minimal sharing with siblings and other household members. Some @entity1 were reported to prefer the new investigational products over traditional complementary food. Considering that the novel @entity24901 was largely acceptable. Efficacy trials are now needed to assess their impact on @entity1 growth and development.
